glp 1 wonder Freethink Windmill Gut Response GLP-1 Support

Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: A randomized, open-label trial

2024;10:e174825

Results revealed that RGC was significantly higher (5.4%) in patients with T2DM on GLP-1 RAs (semaglutide, liraglutide, and dulaglutide) compared to 0.49% in patients without T2DM on GLP-1 RAs ( p -value 0.004) [17]

Neuroscientists describe this as a dampening of dopamine signalling across reward pathways

Am J Gastroenterol 119(6):10281037 Osei SP, Akomaning E, Florut TF, Sodhi M, Lacy BE, Aldhaleei WA, Bhagavathula AS (2024) Gastrointestinal safety assessment of GLP-1 receptor agonists in the US: a real-world adverse events analysis from the FAERS database